Prodrugs of excitatory amino acids

Details for Australian Patent Application No. 2008200612 (hide)

Owner Eli Lilly and Company

Inventors Cano, Ivan Collado; Monn, James Allen; Moher, Erick David; Blanco-Urgoiti, Jaime Gonzalo; Pedregal-Tercero, Concepcion

Agent Spruson & Ferguson

Pub. Number AU-B-2008200612

Parent 2003232146

Filing date 8 February 2008

Wipo publication date 6 March 2008

Acceptance publication date 17 February 2011

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

C07K 5/062 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/065 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/068 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

28 February 2008 Complete Application Filed

6 March 2008 Application Open to Public Inspection

  Published as AU-B-2008200612

17 February 2011 Application Accepted

  Published as AU-B-2008200612

10 March 2011 Corrigenda

  Applications Accepted - Name Index Under the name of Eli Lilly and Company, Application No. 2008200612, under INID (72) correct the co-inventor to Moher, Eric David

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008200613-Tracking web server

2008200611-Methods of treating patients suffering from movement disorders